14 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Branch points: Active ... Active malignancy ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... #Hematology #Anticoagulation
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... Unprovoked • Active ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Unprovoked • Active ... Pulmonary #Embolism #Treatment ... #Algorithm #management ... #hematology #VTE
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Temporary / External Pacing
 • Transvenous & epicardial pacing are temporary methods of supporting brady- &
Transvenous & epicardial ... or definitive treatment ... and more durable treatments ... native cardiac activity ... cardiology #diagnosis #management
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
Diagnosis and Management ... Individual factor activity ... Chronic Management ... center. ... #treatment #hematology
Duration of Treatment of Venous Thromboembolism (VTE)
 - Major transient risk factor (eg, major surgery, major
Duration of Treatment ... Thromboembolism (VTE ... or as long as cancer ... active, whichever ... Thromboembolism #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... Skeletal system • Pericardium ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... Skeletal system • Pericardium ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB